<?xml version="1.0" encoding="UTF-8"?>
<p>Patients were requested to provide a trough blood sample taken immediately prior to everolimus dosing on day 14 of each treatment course to measure the level of mTOR inhibitory activity in their plasma. The methods for measuring this activity are summarized in 
 <italic>Online Supplementary Figure S2</italic> and will be reported more fully elsewhere.
</p>
